297 results on '"Papachristofilou, Alexandros"'
Search Results
2. Management von Keimzelltumoren des Mannes im Stadium I und im Rezidiv
3. Follow-up strategies after trimodal treatment for muscle-invasive bladder cancer: a systematic review
4. Erectile function preservation after salvage radiation therapy for biochemically recurrent prostate cancer after prostatectomy: Five-year results of the SAKK 09/10 randomized phase 3 trial
5. PEACE V—Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial
6. Dose escalation for stereotactic arrhythmia radioablation of recurrent ventricular tachyarrhythmia - a phase II clinical trial
7. Therapy of clinical stage IIA and IIB seminoma: a systematic review
8. Treatment Outcomes for Men with Clinical Stage II Nonseminomatous Germ Cell Tumours Treated with Primary Retroperitoneal Lymph Node Dissection: A Systematic Review
9. Maligne Hodentumoren in der Cisplatin-Ära: Todesursachen und Letalität in einer Kohortenstudie
10. Radiotherapie beim Prostatakarzinom – kurativ und palliativ
11. Single-dose carboplatin followed by involved-node radiotherapy for stage IIA and stage IIB seminoma (SAKK 01/10): a single-arm, multicentre, phase 2 trial
12. Postoperative radiotherapy for meningiomas – a decision-making analysis
13. Adherence to Contouring and Treatment Planning Requirements Within a Multicentric Trial: Results of the Quality Assurance of the SAKK 09/10 trial
14. Gibt es eine Indikation zur Lokaltherapie des mHSPC?
15. Low-Dose Radiation Therapy for Severe COVID-19 Pneumonia: A Randomized Double-Blind Study
16. Therapiemöglichkeiten des Seminoms im klinischen Stadium I und II unter Berücksichtigung der Langzeittoxizität
17. Measures of infection prevention and incidence of SARS-CoV-2 infections in cancer patients undergoing radiotherapy in Germany, Austria and Switzerland
18. Primary bone diffuse large B‐cell lymphoma (PB‐DLBCL): a distinct extranodal lymphoma of germinal centre origin, with a common EZB‐like mutational profile and good prognosis
19. PEACE V—Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial
20. Impact of dose intensified salvage radiation therapy on urinary continence recovery after radical prostatectomy: Results of the randomized trial SAKK 09/10
21. Heart-sparing volumetric modulated arc therapy for whole lung irradiation
22. 2007: Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM)
23. Interdisciplinary Swiss consensus recommendations on staging and treatment of advanced prostate cancer
24. Primary bone diffuse large B‐cell lymphoma (PB‐DLBCL): a distinct extranodal lymphoma of germinal centre origin, with a common EZB‐like mutational profile and good prognosis.
25. Gering retroperitoneal metastasiertes Seminom CS IIA/B: Therapie
26. Radikale Prostatektomie oder „Watchful Waiting“ beim frühen Prostatakarzinom?
27. Salvage Radiotherapy After Radical Prostatectomy
28. Behandlung des gering metastasierten Seminoms
29. Traitement du sminome faiblement mtastatique
30. Primary Bone Diffuse Large B-cell Lymphoma (PB-DLBCL) – a distinct extranodal lymphoma of germinal center origin, with an EZB-like mutational profile and good prognosis
31. Dose escalation for stereotactic arrhythmia radioablation of recurrent ventricular tachyarrhythmia - a phase II clinical trial
32. Interdisciplinary Swiss consensus recommendations on staging and treatment of advanced prostate cancer
33. Radiotherapy for pelvic nodal recurrences after radical prostatectomy: patient selection in clinical practice
34. Impact of patient and treatment characteristics on heart and lung dose in adjuvant radiotherapy for left-sided breast cancer
35. Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer
36. Phase 2, multicenter, randomized study of salvage radiation therapy +/- metformin for recurrent prostate cancer after radical prostatectomy (SAKK 08/15 – GETUG-AFU 34 PROMET trial).
37. Is chemoradiotherapy worth it in metastatic seminoma as first-line treatment? – Authors' reply
38. How Much Chemotherapy Is Required to Optimise Long-term Outcomes in Clinical Stage 2 Seminoma?
39. Salvage radiotherapy for macroscopic local recurrences after radical prostatectomy: A national survey on patterns of practice
40. Aktuelle Rolle der Strahlentherapie bei Keimzelltumoren des Hodens
41. Maligne Hodentumoren in der Cisplatin-Ära: Argumente für moderne Therapiekonzepte
42. Combination of brachytherapy and chemotherapy not superior to pelvic radiotherapy according to GOG-249
43. Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial
44. Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial
45. Consensus and differences in primary radiotherapy for localized and locally advanced prostate cancer in Switzerland: A survey on patterns of practice
46. In regard to Hess et al.
47. Follow-up in non-small-cell lung cancer
48. Radiotherapie beim Prostatakarzinom – kurativ und palliativ
49. Therapy of clinical stage IIA and IIB seminoma: a systematic review
50. Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.